Literature DB >> 30019697

Publisher Correction: Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma.

Shawn T Beug, Caroline E Beauregard, Cristin Healy, Tarun Sanda, Martine St-Jean, Janelle Chabot, Danielle E Walker, Aditya Mohan, Nathalie Earl, Xueqing Lun, Donna L Senger, Stephen M Robbins, Peter Staeheli, Peter A Forsyth, Tommy Alain, Eric C LaCasse, Robert G Korneluk.   

Abstract

This corrects the article DOI: 10.1038/ncomms14278.

Entities:  

Year:  2018        PMID： 30019697      PMCID： PMC6054523          DOI： 10.1038/ncomms16231

Source DB:  PubMed          Journal:  Nat Commun        ISSN： 2041-1723            Impact factor:   14.919


The original HTML version of this Article omitted the article number; it should have been ‘14278’. This has now been corrected in the HTML version of the Article. The PDF version was correct from the time of publication.
  3 in total

Review 1.  Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy.

Authors:  Weitong Gao; Xueying Wang; Yang Zhou; Xueqian Wang; Yan Yu
Journal:  Signal Transduct Target Ther       Date:  2022-06-20

2.  Clinical MDR1 inhibitors enhance Smac-mimetic bioavailability to kill murine LSCs and improve survival in AML models.

Authors:  Emma Morrish; Anthony Copeland; Donia M Moujalled; Jason A Powell; Natasha Silke; Ann Lin; Kate E Jarman; Jarrod J Sandow; Gregor Ebert; Liana Mackiewicz; Jessica A Beach; Elizabeth L Christie; Alexander C Lewis; Giovanna Pomilio; Karla C Fischer; Laura MacPherson; David D L Bowtell; Andrew I Webb; Marc Pellegrini; Mark A Dawson; Stuart M Pitson; Andrew H Wei; John Silke; Gabriela Brumatti
Journal:  Blood Adv       Date:  2020-10-27

3.  Integrated drug profiling and CRISPR screening identify essential pathways for CAR T-cell cytotoxicity.

Authors:  Olli Dufva; Jan Koski; Pilvi Maliniemi; Aleksandr Ianevski; Jay Klievink; Judith Leitner; Petri Pölönen; Helena Hohtari; Khalid Saeed; Tiina Hannunen; Pekka Ellonen; Peter Steinberger; Matti Kankainen; Tero Aittokallio; Mikko A I Keränen; Matti Korhonen; Satu Mustjoki
Journal:  Blood       Date:  2020-02-27       Impact factor: 22.113
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.